NOI -Illumina Infinium Methylation Screening Array
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a non-competitive combined synopsis/solicitation (number 75N98026Q00600) for the procurement of twenty Infinium Methylation Screening Array-48 Kits from Illumina, Inc. This firm-fixed-price purchase order will support the NHLBI Division of Intramural Research, specifically the Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LoGICO). Illumina is the sole manufacturer of this proprietary BeadChip product, which is protected by patents and trade secrets, and is uniquely compatible with the existing Illumina iScan System and Infinium Automated Pipetting System installed at the NIA Laboratory of Neurogenetics. No other vendor offers a functionally equivalent product, and Illumina has confirmed it has not authorized any intermediaries to supply this item. The acquisition is conducted under the streamlined solicitation authority for commercial items as specified in FAR Subpart 12.6 and FAR 12.603, and it does not exceed the simplified acquisition threshold. It is not set aside for small businesses, falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing, with a size standard of 1,250 employees. The solicitation incorporates clauses effective through the Federal Acquisition Circular 2026-01. Responses are due by June 18, 2026, and the point of contact for this procurement is Nicholas S. Capobianco of NIH.
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
(ii) The solicitation number is 75N98026Q00600. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (brand-name).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Illumina, Inc., 5200 Illumina Way, San Diego, CA 92122 for twenty (20) Infinium Methylation Screening Array-48 Kits (Catalog No. 20112611) in support of the NHLBI Division of Intramural Research, Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LoGICO). Illumina is the sole manufacturer and source of the Infinium Methylation Screening Array, a proprietary BeadChip product protected by patents and trade secrets, and the only methylation array compatible with the Illumina iScan System and Infinium Automated Pipetting System with ILASS already installed at the NIA Laboratory of Neurogenetics where the assays will be performed. No other manufacturer produces a functionally equivalent product, and Illumina has certified in writing that it has not authorized any third-party intermediary to provide the Illumina products required for this transaction (Quotation No. 4791799).
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026.
(iv) The associated NAICS code is 325413 ¿ In-Vitro Diagnostic Substance Manufacturing, and the small business size standard is 1,250 employees. This requirement is not set aside for small business.